blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3580344

EP3580344 - VCN ENHANCER COMPOSITIONS AND METHODS OF USING THE SAME [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.06.2023
Database last updated on 19.10.2024
FormerExamination is in progress
Status updated on  20.08.2021
FormerRequest for examination was made
Status updated on  15.11.2019
FormerThe international publication has been made
Status updated on  18.08.2018
Most recent event   Tooltip23.06.2023Application deemed to be withdrawnpublished on 26.07.2023  [2023/30]
Applicant(s)For all designated states
2seventy bio, Inc.
60 Binney Street
Cambridge, MA 02142 / US
[2021/43]
Former [2019/51]For all designated states
Bluebird Bio, Inc.
60 Binney Street
Cambridge, MA 02142 / US
Inventor(s)01 / DIACONU, Iulia
c/o bluebird bio Inc.
60 Binney Street
Cambridge Massachusetts 02142 / US
02 / PARSONS, Geoffrey B.
17 Castleton Street
Jamaica Plain Massachusetts 02130 / US
 [2019/51]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2019/51]Cooley (UK) LLP
Dashwood
69 Old Broad Street
London EC2M 1QS / GB
Application number, filing date18751122.509.02.2018
[2019/51]
WO2018US17557
Priority number, dateUS201762457504P10.02.2017         Original published format: US 201762457504 P
[2019/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018148502
Date:16.08.2018
Language:EN
[2018/33]
Type: A1 Application with search report 
No.:EP3580344
Date:18.12.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 16.08.2018 takes the place of the publication of the European patent application.
[2019/51]
Search report(s)International search report - published on:US16.08.2018
(Supplementary) European search report - dispatched on:EP16.10.2020
ClassificationIPC:C12N15/86, A61K9/00, A61K39/00, A61K47/10, A61P35/00
[2020/47]
CPC:
C12N15/86 (EP,US); A61K35/17 (US); A61K39/461 (EP);
A61K39/4631 (EP); A61K39/4632 (EP); A61K39/464488 (EP);
A61K47/10 (EP,US); A61K9/0019 (EP,US); A61P35/00 (EP);
A61K31/4439 (US); A61K31/4709 (US); A61K31/52 (US);
A61K31/5377 (US); C07K14/7051 (EP); C07K2319/03 (EP);
C12N2740/16043 (EP,US) (-)
Former IPC [2019/51]C12N15/86, A61K48/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/51]
TitleGerman:VCN-FÖRDERER-ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON[2019/51]
English:VCN ENHANCER COMPOSITIONS AND METHODS OF USING THE SAME[2019/51]
French:COMPOSITIONS D'AUGMENTATION DU NCV ET PROCÉDÉS D'UTILISATION DE CES DERNIÈRES[2019/51]
Entry into regional phase29.08.2019National basic fee paid 
29.08.2019Search fee paid 
29.08.2019Designation fee(s) paid 
29.08.2019Examination fee paid 
Examination procedure29.08.2019Examination requested  [2019/51]
06.05.2021Amendment by applicant (claims and/or description)
24.08.2021Despatch of a communication from the examining division (Time limit: M06)
27.05.2022Reply to a communication from the examining division
18.10.2022Despatch of a communication from the examining division (Time limit: M04)
01.03.2023Application deemed to be withdrawn, date of legal effect  [2023/30]
22.03.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2023/30]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
27.05.2022Request for further processing filed
27.05.2022Full payment received (date of receipt of payment)
Request granted
07.06.2022Decision despatched
Fees paidRenewal fee
10.02.2020Renewal fee patent year 03
02.02.2021Renewal fee patent year 04
18.02.2022Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
28.02.202306   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]WO2013127964  (HELMHOLTZ ZENTRUM MUENCHEN [DE], et al) [YD] 1-13 * examples 2, 6; claims 1-6; table 1 *;
 [Y]WO2016201394  (MILTENYI BIOTEC TECH INC [US]) [Y] 1-13* page 7 - page 10; examples 5, 8 *
International search[Y]US2014255363  (METELITSA LEONID S [US], et al) [Y] 2, 3/2, 5, 81, 82/81, 84* Claims 1, 6, 15; para [0025] *;
 [XY]  - HOFIG et al., "Poloxamer synperonic F108 improves cellular transduction. with lentiviral vectors", J Gene Med, (20120800), vol. 14, no. 8, pages 549 - 560, XP055061427 [X] 1, 3/1, 80, 82/80 * ; abstract, pg 551, col 1, para 4 to col 2, para 1, pg 552, Table 1, pg 558, col 1, para 1, Fig. 6b * [Y] 2, 3/2, 5, 81, 82/81, 84

DOI:   http://dx.doi.org/10.1002/jgm.2653
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.